NASDAQ:PTI - Proteostasis Therapeutics News Headlines

$1.05
+0.01 (+0.96 %)
(As of 06/19/2019 09:23 AM ET)
Today's Range
$1.02
Now: $1.05
$1.09
50-Day Range
$0.95
MA: $1.04
$1.13
52-Week Range
$0.91
Now: $1.05
$10.38
Volume743,669 shs
Average Volume1.74 million shs
Market Capitalization$53.66 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.65

Headlines

Proteostasis Therapeutics (NASDAQ PTI) News Headlines

Source:
DateHeadline
How Proteostasis Therapeutics, Inc. (NASDAQ:PTI) Could Add Value To Your PortfolioHow Proteostasis Therapeutics, Inc. (NASDAQ:PTI) Could Add Value To Your Portfolio
finance.yahoo.com - June 14 at 6:31 PM
Proteostasis Therapeutics Inc (NASDAQ:PTI) Receives Average Rating of "Buy" from AnalystsProteostasis Therapeutics Inc (NASDAQ:PTI) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - June 11 at 6:41 AM
Proteostasis Therapeutics Rallies After Cystic Fibrosis Drug Is Granted Orphan DesignationProteostasis Therapeutics Rallies After Cystic Fibrosis Drug Is Granted Orphan Designation
www.benzinga.com - June 4 at 4:00 PM
Proteostasis Therapeutics Receives Orphan Drug Designation in the EU for PTI-428 for the Treatment of Cystic FibrosisProteostasis Therapeutics Receives Orphan Drug Designation in the EU for PTI-428 for the Treatment of Cystic Fibrosis
finance.yahoo.com - June 4 at 11:54 AM
Proteostasis Therapeutics Announces Presentations and Hosts Educational Symposium at the 42nd European Cystic Fibrosis ConferenceProteostasis Therapeutics Announces Presentations and Hosts Educational Symposium at the 42nd European Cystic Fibrosis Conference
finance.yahoo.com - June 3 at 10:59 AM
Proteostasis Therapeutics to Present at the 2019 RBC Capital Markets Global Healthcare ConferenceProteostasis Therapeutics to Present at the 2019 RBC Capital Markets Global Healthcare Conference
finance.yahoo.com - May 15 at 11:35 AM
Proteostasis: 1Q Earnings SnapshotProteostasis: 1Q Earnings Snapshot
finance.yahoo.com - May 9 at 11:49 AM
Proteostasis Therapeutics (PTI) Reports Q1 Loss, Tops Revenue EstimatesProteostasis Therapeutics (PTI) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 9 at 11:49 AM
Proteostasis (PTI) to Post Q1 Earnings: Whats in Store?Proteostasis (PTI) to Post Q1 Earnings: What's in Store?
finance.yahoo.com - May 7 at 11:38 AM
Proteostasis (PTI) to Post Q1 Earnings: What's in Store?Proteostasis (PTI) to Post Q1 Earnings: What's in Store?
finance.yahoo.com - May 7 at 11:38 AM
Market Sentiment Around Loss-Making Proteostasis Therapeutics, Inc. (NASDAQ:PTI)Market Sentiment Around Loss-Making Proteostasis Therapeutics, Inc. (NASDAQ:PTI)
finance.yahoo.com - May 2 at 11:50 AM
Analysts Estimate Proteostasis Therapeutics (PTI) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Proteostasis Therapeutics (PTI) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - May 1 at 11:26 AM
Some Proteostasis Therapeutics (NASDAQ:PTI) Shareholders Have Taken A Painful 86% Share Price DropSome Proteostasis Therapeutics (NASDAQ:PTI) Shareholders Have Taken A Painful 86% Share Price Drop
finance.yahoo.com - March 26 at 3:59 PM
Proteostasis Plunges on Weak Data From Cystic Fibrosis StudyProteostasis Plunges on Weak Data From Cystic Fibrosis Study
finance.yahoo.com - March 26 at 3:59 PM
The Daily Biotech Pulse: Japanese Cheer For AbbVie, Myokardia Offering, CytomX CFO DepartsThe Daily Biotech Pulse: Japanese Cheer For AbbVie, Myokardia Offering, CytomX CFO Departs
finance.yahoo.com - March 26 at 12:13 PM
Proteostasis Therapeuticss stock plunges to pace all decliners after results of CF treatment trial disappointProteostasis Therapeutics's stock plunges to pace all decliners after results of CF treatment trial disappoint
www.marketwatch.com - March 25 at 4:07 PM
Proteostasis Therapeutics's stock plunges to pace all decliners after results of CF treatment trial disappointProteostasis Therapeutics's stock plunges to pace all decliners after results of CF treatment trial disappoint
finance.yahoo.com - March 25 at 4:07 PM
Proteostatis stock plunges on cystic fibrosis triple combo dataProteostatis stock plunges on cystic fibrosis triple combo data
finance.yahoo.com - March 25 at 4:07 PM
Why Vertex's Grip On This Huge Sales Opportunity Now Looks UnbreakableWhy Vertex's Grip On This Huge Sales Opportunity Now Looks Unbreakable
finance.yahoo.com - March 25 at 4:07 PM
Proteostasis down 48% premarket on disappointing data on CF candidatesProteostasis down 48% premarket on disappointing data on CF candidates
seekingalpha.com - March 25 at 10:12 AM
Proteostasis Therapeutics Announces Broad New Dataset from Proprietary Combination and Add-On CFTR Modulator Studies in Cystic Fibrosis PatientsProteostasis Therapeutics Announces Broad New Dataset from Proprietary Combination and Add-On CFTR Modulator Studies in Cystic Fibrosis Patients
finance.yahoo.com - March 25 at 10:12 AM
Proteostasis Therapeutics IncProteostasis Therapeutics Inc
www.bloomberg.com - March 19 at 9:52 AM
Proteostasis Therapeutics, Inc. Estimate MomentumProteostasis Therapeutics, Inc. Estimate Momentum
www.nasdaq.com - March 18 at 4:02 PM
Proteostasis Therapeutics Appoints David Arkowitz to Board of Directors - PRNewswireProteostasis Therapeutics Appoints David Arkowitz to Board of Directors - PRNewswire
www.prnewswire.com - March 8 at 4:16 PM
Vertex's VX-445 Triple Combo Cystic Fibrosis Trials SucceedVertex's VX-445 Triple Combo Cystic Fibrosis Trials Succeed
finance.yahoo.com - March 7 at 12:20 PM
Proteostasis Selected to Join European Consortium to Pioneer Personalized Medicine in Cystic FibrosisProteostasis Selected to Join European Consortium to Pioneer Personalized Medicine in Cystic Fibrosis
finance.yahoo.com - February 27 at 12:07 PM
Proteostasis Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare ConferenceProteostasis Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 20 at 12:12 PM
How Much Of Proteostasis Therapeutics, Inc. (NASDAQ:PTI) Do Institutions Own?How Much Of Proteostasis Therapeutics, Inc. (NASDAQ:PTI) Do Institutions Own?
finance.yahoo.com - February 7 at 3:59 PM
Biotech Stocks Set to PopBiotech Stocks Set to Pop
finance.yahoo.com - February 7 at 11:28 AM
4 Biotech Stocks Making Moves on Wednesday (2/6/19)4 Biotech Stocks Making Moves on Wednesday (2/6/19)
finance.yahoo.com - February 6 at 4:03 PM
Form 3 PROTEOSTASIS THERAPEUTIC For: Feb 01 Filed by: Drapkin Kimberlee C - StreetInsider.comForm 3 PROTEOSTASIS THERAPEUTIC For: Feb 01 Filed by: Drapkin Kimberlee C - StreetInsider.com
www.streetinsider.com - February 6 at 11:21 AM
Form SC 13G/A PROTEOSTASIS THERAPEUTIC Filed by: PRUDENTIAL FINANCIAL INC - StreetInsider.comForm SC 13G/A PROTEOSTASIS THERAPEUTIC Filed by: PRUDENTIAL FINANCIAL INC - StreetInsider.com
www.streetinsider.com - February 2 at 3:53 PM
Proteostasis up 8% after hours on successful Phase 1 study of PTI-428Proteostasis up 8% after hours on successful Phase 1 study of PTI-428
seekingalpha.com - January 1 at 9:52 AM
BRIEF-Proteostasis Therapeutics Provides Clinical Enrollment UpdateBRIEF-Proteostasis Therapeutics Provides Clinical Enrollment Update
www.msn.com - December 21 at 10:12 AM
Proteostasis down 11% after hours on delay in data readout from early-stage study of CF triplet therapyProteostasis down 11% after hours on delay in data readout from early-stage study of CF triplet therapy
seekingalpha.com - December 21 at 10:12 AM
Proteostasis Therapeutics Provides Clinical Enrollment UpdateProteostasis Therapeutics Provides Clinical Enrollment Update
finance.yahoo.com - December 21 at 10:12 AM
How Many Insiders Bought Proteostasis Therapeutics, Inc. (NASDAQ:PTI) Shares?How Many Insiders Bought Proteostasis Therapeutics, Inc. (NASDAQ:PTI) Shares?
finance.yahoo.com - December 20 at 4:08 PM
The Upcoming Readout For Proteostasis Is In A Make Or Break SituationThe Upcoming Readout For Proteostasis Is In A Make Or Break Situation
seekingalpha.com - December 19 at 10:27 AM
Proteostasis Therapeutics Announces Global License Agreement with Genentech - PRNewswireProteostasis Therapeutics Announces Global License Agreement with Genentech - PRNewswire
www.prnewswire.com - December 18 at 4:08 PM
This Weeks Top Tech Earnings and Todays Trending Stocks: PTI & NBEVThis Week's Top Tech Earnings and Today's Trending Stocks: PTI & NBEV
finance.yahoo.com - December 17 at 3:52 PM
Meet the New Big Proteostasis Licensing AgreementMeet the New Big Proteostasis Licensing Agreement
247wallst.com - December 17 at 3:52 PM
Proteostasis Therapeutics (PTI) Reports Global License Agreement with GenentechProteostasis Therapeutics (PTI) Reports Global License Agreement with Genentech
www.streetinsider.com - December 17 at 3:52 PM
Proteostasis Therapeutics Rallies On Genentech Licensing AgreementProteostasis Therapeutics Rallies On Genentech Licensing Agreement
finance.yahoo.com - December 17 at 3:52 PM
This Week's Top Tech Earnings and Today's Trending Stocks: PTI & NBEVThis Week's Top Tech Earnings and Today's Trending Stocks: PTI & NBEV
finance.yahoo.com - December 17 at 3:52 PM
Biotech News: Proteostasis Therapeutics (PTI) Stock Soars on GenentechBiotech News: Proteostasis Therapeutics (PTI) Stock Soars on Genentech
investorplace.com - December 17 at 1:25 PM
PTI, AXON among premarket gainersPTI, AXON among premarket gainers
seekingalpha.com - December 17 at 10:42 AM
Proteostasiss stock jumps after license deal with GenentechProteostasis's stock jumps after license deal with Genentech
www.marketwatch.com - December 17 at 10:42 AM
Proteostasis Therapeutics Inc.Proteostasis Therapeutics Inc.
www.barrons.com - December 17 at 10:42 AM
Proteostasis Therapeutics inks deal with Genentech; shares up 19% premarketProteostasis Therapeutics inks deal with Genentech; shares up 19% premarket
seekingalpha.com - December 17 at 10:42 AM
Proteostasis Therapeutics Announces Global License Agreement with GenentechProteostasis Therapeutics Announces Global License Agreement with Genentech
finance.yahoo.com - December 17 at 10:42 AM
This page was last updated on 6/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel